Introducing MedTech IP Litigation Strategy & Exchange
This year, the Tech & Innovation Patent Litigation track will host the MedTech IP Litigation Strategy & Exchange, created in response to industry demand for MedTech-specific content and the growing patent litigation challenges at the intersection of technology and healthcare.
This dedicated route brings together senior in-house counsel and private practice litigators to address the issues shaping patent disputes across medical devices, diagnostics, and digital health.
The MedTech IP Litigation Strategy & Exchange Route integrates the topics most relevant to MedTech into a focused sequence of sessions across Tuesday afternoon and Wednesday morning, allowing MedTech attendees to maximise their time within the Tech & Innovation track while engaging with industry-specific litigation strategy.
Across the programme, you will participate in dedicated plenary discussions, roundtables, networking opportunities, and meeting spaces designed specifically for the MedTech IP community, bringing together 50+ senior MedTech in-house counsel from across the industry.
The programme includes:
- MedTech-focused roundtables on Tuesday afternoon, enabling targeted discussion on the most pressing litigation challenges facing the sector.
- A MedTech plenary session on Wednesday morning:
Litigation Challenges in the MedTech Sector: Regulatory Entanglement, NPEs & Competitor Suits. - Industry-specific networking opportunities, including an invite-only MedTech Leadership Breakfast on Wednesday morning and MedTech networking lunches on Tuesday and Wednesday.
- MedTech perspectives embedded across key Tech & Innovation plenary sessions, ensuring the sector’s litigation priorities are represented throughout the programme.
Why Attend
- A first-of-its-kind MedTech litigation forum
Engage in a dedicated programme focused on the patent litigation dynamics shaping the MedTech sector, including competitor disputes, NPE activity, and regulatory overlap. - Dedicated MedTech discussion spaces
Connect directly with MedTech-focused in-house in dedicated networking spaces and sessions, and 1-1 meetings designed for the sector. - Unmatched in-house participation
Join 40+ senior in-house IP counsel to gain commercial insight, benchmark litigation strategy, and discuss the challenges unique to MedTech innovation and enforcement. - Senior MedTech speaking faculty
Hear directly from the decision-makers behind some of the industry’s most significant patent disputes and gain practical insights you can apply to your own litigation strategy. - Substantive, industry-specific content
Built with direct input from senior MedTech in-house counsel, the programme focuses on the legal, regulatory, and commercial dynamics that shape MedTech patent litigation.





